FI931292A7 - Haavoja parantavat pyridyylioksijohdannaiset, niiden valmistus ja käytöt - Google Patents

Haavoja parantavat pyridyylioksijohdannaiset, niiden valmistus ja käytöt Download PDF

Info

Publication number
FI931292A7
FI931292A7 FI931292A FI931292A FI931292A7 FI 931292 A7 FI931292 A7 FI 931292A7 FI 931292 A FI931292 A FI 931292A FI 931292 A FI931292 A FI 931292A FI 931292 A7 FI931292 A7 FI 931292A7
Authority
FI
Finland
Prior art keywords
preparation
wound healing
pyridyloxy derivatives
pyridyloxy
derivatives
Prior art date
Application number
FI931292A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI931292A0 (fi
FI931292L (fi
Inventor
Hiroshi Fukumi
Mitsuo Sugiyama
Koichi Kojima
Keiichi Tabata
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of FI931292A0 publication Critical patent/FI931292A0/fi
Publication of FI931292L publication Critical patent/FI931292L/fi
Publication of FI931292A7 publication Critical patent/FI931292A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Cleaning And De-Greasing Of Metallic Materials By Chemical Methods (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
FI931292A 1992-03-23 1993-03-23 Haavoja parantavat pyridyylioksijohdannaiset, niiden valmistus ja käytöt FI931292A7 (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP6532492 1992-03-23
JP10139292 1992-04-21
JP17570792 1992-07-02
JP34903592 1992-12-28

Publications (3)

Publication Number Publication Date
FI931292A0 FI931292A0 (fi) 1993-03-23
FI931292L FI931292L (fi) 1993-09-24
FI931292A7 true FI931292A7 (fi) 1993-09-24

Family

ID=27464571

Family Applications (1)

Application Number Title Priority Date Filing Date
FI931292A FI931292A7 (fi) 1992-03-23 1993-03-23 Haavoja parantavat pyridyylioksijohdannaiset, niiden valmistus ja käytöt

Country Status (19)

Country Link
US (1) US5616579A (OSRAM)
EP (1) EP0562833B1 (OSRAM)
JP (1) JPH06247933A (OSRAM)
CN (1) CN1081437A (OSRAM)
AT (1) ATE137748T1 (OSRAM)
AU (1) AU659922B2 (OSRAM)
CA (1) CA2092111A1 (OSRAM)
CZ (1) CZ47493A3 (OSRAM)
DE (1) DE69302515T2 (OSRAM)
DK (1) DK0562833T3 (OSRAM)
ES (1) ES2090859T3 (OSRAM)
FI (1) FI931292A7 (OSRAM)
GR (1) GR3020069T3 (OSRAM)
HK (1) HK159796A (OSRAM)
HU (1) HUT64053A (OSRAM)
IL (1) IL105140A (OSRAM)
NO (1) NO931041L (OSRAM)
NZ (1) NZ247229A (OSRAM)
TW (1) TW240222B (OSRAM)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1251474B (it) * 1991-09-13 1995-05-15 Mini Ricerca Scient Tecnolog Derivati ossimici ad attivita' fungicida
JP4058129B2 (ja) * 1996-03-18 2008-03-05 株式会社資生堂 ピリジン誘導体及び抗潰瘍剤、抗菌剤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS568352A (en) * 1979-07-03 1981-01-28 Shionogi & Co Ltd Aminoalkylvenzene derivative
US4300549A (en) * 1980-01-07 1981-11-17 Surgikos Operating room face mask
JPS6185365A (ja) 1984-10-02 1986-04-30 Ikeda Mohandou:Kk アミノアルキルピリジルオキシ誘導体
US4837316A (en) * 1985-08-29 1989-06-06 Fujirebio Kabushiki Kaisha Alkylamide derivatives with H2 -receptor antagonistic and cytoprotective action
JPS63225371A (ja) 1987-03-13 1988-09-20 Fujirebio Inc ピリジルオキシ誘導体
US4912101A (en) * 1987-03-13 1990-03-27 Fujirebio Kabushiki Kaisha 4-aminomethyl-pyridyl-2-oxy derivatives having anti-ulcer activity
JPH0639466B2 (ja) * 1987-08-03 1994-05-25 杏林製薬株式会社 ウレア誘導体
JPH0193247A (ja) * 1987-10-05 1989-04-12 Toshiba Corp マルチノードシステム
JPH0637472B2 (ja) 1988-01-29 1994-05-18 富士レビオ株式会社 ピリジルオキシ誘導体
EP0404949A4 (en) * 1988-07-05 1991-07-17 Zeria Pharmaceutical Co., Ltd. Substituted acetamide derivatives, process for their preparation and antiulcer drug containing same
ATE116343T1 (de) * 1990-03-06 1995-01-15 Akzo Nobel Nv Wässrige hybridpolymerdispersion und beschichtungszusammensetzung.
JPH04257581A (ja) * 1991-02-08 1992-09-11 Kyorin Pharmaceut Co Ltd ピペリジノメチルピリジン誘導体

Also Published As

Publication number Publication date
CN1081437A (zh) 1994-02-02
IL105140A0 (en) 1993-07-08
HUT64053A (en) 1993-11-29
ATE137748T1 (de) 1996-05-15
EP0562833B1 (en) 1996-05-08
FI931292A0 (fi) 1993-03-23
NO931041D0 (no) 1993-03-23
US5616579A (en) 1997-04-01
FI931292L (fi) 1993-09-24
HK159796A (en) 1996-08-30
AU659922B2 (en) 1995-06-01
CA2092111A1 (en) 1993-09-24
GR3020069T3 (en) 1996-08-31
NO931041L (no) 1993-09-24
ES2090859T3 (es) 1996-10-16
EP0562833A1 (en) 1993-09-29
DE69302515D1 (de) 1996-06-13
JPH06247933A (ja) 1994-09-06
TW240222B (OSRAM) 1995-02-11
DE69302515T2 (de) 1997-01-09
IL105140A (en) 1997-01-10
DK0562833T3 (da) 1996-09-09
NZ247229A (en) 1994-10-26
HU9300827D0 (en) 1993-06-28
CZ47493A3 (en) 1993-12-15
AU3537993A (en) 1993-09-30

Similar Documents

Publication Publication Date Title
FI955248A7 (fi) 1-Bifenyylimetyyli-imitdatsolin johdannaiset, niiden valmistus ja terapeuttinen käyttö
FI955235L (fi) Oksatsolidiinionijohdannaiset, niiden valmistus ja käyttö
FI982761L (fi) Bentsimidatsolijohdannaiset, niiden valmistus ja kiteet
FI935074A7 (fi) Uusia tiopyranopyrrolijohdannaisia ja niiden valmistus
FI935897A7 (fi) Pyridopyrimidiinijohdannaiset, niiden valmistus ja käyttö
FI954763A7 (fi) Oksiinijohdannaiset, niiden valmistus ja niiden terapeuttinen käyttö
FI935887A7 (fi) Tiatzolidiinidionijohdannaiset, niiden valmistus ja käyttö
FI921459A7 (fi) Piperidiinijohdannaiset, niiden valmistus ja terapeuttinen käyttö
FI922983A7 (fi) Pyrimidiini-4-karboksamidijohdannaisia, niiden valmistus ja terapeuttinen käyttö
FI914611A7 (fi) 2-aminopyrimidiini-4-karboksamidijohdannaiset, niiden valmistus ja terapeuttinen käyttö
FI935801L (fi) Imidatsoliyhdisteitä, niiden valmistus ja käyttö
FI925501A7 (fi) Imidatsoliyhdisteitä, niiden valmistus ja käyttö
FI941068A7 (fi) Bentsoksatsiinijohdannaiset, niiden valmistus ja terapeuttinen käyttö
FI922982A7 (fi) 2-aminopyrimidiini-4-karboksamidijohdannaisia, niiden valmistus ja niiden terapeuttinen käyttö
FI934680A7 (fi) Aryylimorfoliini, valmistus ja käyttö
FI930716A7 (fi) Uusia aryylikarbonyyliaminoalkyylidihydro-oksopyridiinejä, niiden valmistus ja käyttö
FI933544A7 (fi) Tiadiatsiinikarboksamidijohdannaiset, menetelmät niiden valmistamiseks i ja lääkkeet
FI934221A7 (fi) Piperidiinijohdannaiset, niiden valmistus ja terapeuttinen käyttö
FI921814A7 (fi) 2-aminopyrimidiini-4-karboksiamidijohdannaiset, niiden valmistus ja terapeuttinen käyttö
FI920663A7 (fi) Polyhydroksisyklopentaanin johdannaiset, niiden valmistus ja terapeuttinen käyttö
FI925850A7 (fi) Pyridyylitiatsolidinikarboksyylihapon amidijohdannaiset, niiden valmistus ja niiden terapeuttiset käytöt
FI941963L (fi) Pyridiinijohdannaiset, niiden valmistus ja käyttö
FI924053A7 (fi) Substituoidut aminopropaanit, menetelmä niiden valmistamiseksi ja niiden käyttö
FI914525A7 (fi) Yhdiste, käyttö ja valmistus
FI922980A7 (fi) 2-piperidinyylipyrimidiini-4-karboksamidijohdannaiset, niiden valmistus ja terapeuttinen käyttö

Legal Events

Date Code Title Description
FD Application lapsed